2018 Fiscal Year Final Research Report
Development of specific molecular target therapy for oral cancer using new drug delivery system
Project/Area Number |
16K11698
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Tohoku University (2017-2018) Kyushu Dental College (2016) |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
西原 達次 九州歯科大学, 歯学部, 特任教授 (80192251)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Keywords | 癌 / ソノポレーション / マイクロバブル |
Outline of Final Research Achievements |
Sonoporation is a drug and gene delivery system using ultrasonication that allows the intracellular delivery of foreign molecules that cannot enter cells under normal conditions.In this study, we developed anti-epidermal growth factor receptor (EGFR) antibody-conjugated Microbubbles (EGFR-MBs) and evaluated their capacity to enhance anti-cancer drug toxicity in vitro and in vivo. Bleomycin delivery using sonoporation with EGFR-MBs was significantly more toxic to the cells compared with the other groups.We next examined the effect of EGFR-MBs in a murine squamous cell carcinoma model. Bleomycin delivery by sonoporation with EGFR-MBs exhibited remarkable antitumor activity. We focused novel platinum nanoparticles-conjugated latex beads, platinum nanocomposite(PtNCP) beads, and investigated the possibility to incorporate novel anti-cancer effect of these combined nanoparticles. PtNCP beads treatment suppressed tumor growth and identified increasing pathological necrotic areas, in vivo.
|
Free Research Field |
口腔外科
|
Academic Significance and Societal Importance of the Research Achievements |
舌癌などは、表層から超音波を当てることができ,ソノポレーション法を用いる部位として適している.抗EGFR抗体修飾マイクロバブルは表面が水溶性ポリエチレングリコールで修飾されているため,肝臓などを中心とする細網内皮系組織の貪食細胞に処理されず,血中に長時間循環滞留することができる.バブルに抗EGFR抗体を結合させることにより,より選択的に癌局所へ抗癌物質を集積することができる.これらのバブルを用いれば,ターゲットとなる癌組織にバブルを集積させ,体外からの超音波診断とともに,治療用超音波エネルギーで,非侵襲的に抗癌剤を導入できる.口腔癌の治療を始め,様々な難治性疾患の治療に応用可能である.
|